Status:
COMPLETED
Non- Clinical Coagulation Activation During Hemodialysis
Lead Sponsor:
Universitair Ziekenhuis Brussel
Conditions:
Kidney Diseases
End Stage Renal Disease
Eligibility:
All Genders
18+ years
Brief Summary
Every patient included in the study will undergo 1 conventional hemodialysis treatment, ie 1 study visit. During the conventional hemodialysis treatment lasting 4 hours, 2 blood samples will be taken ...
Eligibility Criteria
Inclusion
- ≥ 18 years of age.
- Patients able and agree to provide signed informed consent.
Exclusion
- Known allergy for polysulphone dialysis membrane.
- Use of vitamin K antagonists or novel oral anticoagulant therapy.
- Use of chronic heparin treatment, UFH or LMWH.
Key Trial Info
Start Date :
October 25 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2019
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04063423
Start Date
October 25 2018
End Date
May 1 2019
Last Update
August 21 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Brussel
Jette, Belgium, 1090